Interferon‐γ biphasically regulates angiotensinogen expression via a JAK‐STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells
Open Access
- 1 February 2012
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 26 (5) , 1821-1830
Abstract
Renal inflammation modulates angiotensinogen (AGT) production in renal proximal tubular cells (RPTCs) via inflammatory cytokines, including interleukin‐6, tumor necrosis factor α, and interferon‐γ (IFN‐γ). Among these, the effects of IFN‐γ on AGT regulation in RPTCs are incompletely delineated. This study aimed to elucidate mechanisms by which IFN‐γ regulates AGT expression in RPTCs. RPTCs were incubated with or without IFN‐γ up to 48 h. AGT expression, STAT1 and STAT3 activities, and SOCS1 expression were evaluated. RNA interference studies against STAT1, SOCS1, and STAT3 were performed to elucidate a signaling cascade. IFN‐γ decreased AGT expression at 6 h (0.61 ±0.05, ratio to control) and 12 h (0.47±0.03). In contrast, longer exposure for 24 and 48 h increased AGT expression (1.76±0.18, EC 50 = 3.4 ng/ml, and 1.45±0.08, respectively). IFN‐γ treatment for 6 h strongly induced STAT1 phosphorylation and SOCS1 augmentation, and decreased STAT3 activity. However, STAT1 phosphorylation and SOCS1 augmentation waned at 24 h, while STAT3 activity increased. RNA interference studies revealed that activation of STAT1‐SOCS1 axis decreased STAT3 activity. Thus, IFN‐γ biphasically regulates AGT expression in RPTCs via STAT3 activity modulated by STAT1‐SOCS1 axis, suggesting the STAT1‐SOCS1 axis is important in IFN‐γ‐induced activation of the intrarenal renin‐angiotensin system.—Satou, R., Miyata, K., Gonzalez‐Villalobos, R. A., Ingelfinger, J. R., Navar, L. G., Kobori, H. Interferon‐γ biphasically regulates angiotensinogen expression via a JAK‐STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J. 26, 1821‐1830 (2012). www.fasebj.orgKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072408, K99DK083455)
- National Center for Research Resources (P20RR017659)
- National Heart, Lung, and Blood Institute (R01HL026371)
This publication has 45 references indexed in Scilit:
- Intrarenal angiotensin II and its contribution to the genesis of chronic hypertensionCurrent Opinion in Pharmacology, 2011
- Tumor necrosis factor-α suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cellsAmerican Journal of Physiology-Cell Physiology, 2010
- IL-6 augments angiotensinogen in primary cultured renal proximal tubular cellsMolecular and Cellular Endocrinology, 2009
- Intracellular Delivery of a Cell-Penetrating SOCS1 that Targets IFN-γ SignalingScience Signaling, 2009
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genesProceedings of the National Academy of Sciences, 2009
- Fibroblast growth factor inhibits interferon γ-STAT1 and interleukin 6-STAT3 signaling in chondrocytesCellular Signalling, 2009
- Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused miceAmerican Journal of Physiology-Renal Physiology, 2008
- Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cellsAmerican Journal of Physiology-Renal Physiology, 2008
- Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISAAmerican Journal of Physiology-Renal Physiology, 2008
- The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney DiseasePharmacological Reviews, 2007